Facts About cholinergic receptors and their distribution Revealed
It really is notable that in scientific trials, a reduced incidence of CNS alterations and CNS adverse events is described with oxybutynin extended launch (ER) and tolterodine ER, and these activities were being seldom a cause for discontinuation (see Clemett & Jarvis, 2001; Chu et alIt is important to consider whether or not the role of muscarinic